E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/4/2018 in the Prospect News Distressed Debt Daily.

Egalet wins court approval to use secured creditors’ cash collateral

By Caroline Salls

Pittsburgh, Dec. 4 – Egalet Corp. obtained final court approval to use the cash collateral of its pre-bankruptcy secured creditors, according to an order filed Tuesday with the U.S. Bankruptcy Court for the District of Delaware.

As previously reported, the cash collateral will be used to fund the company’s operations while in bankruptcy.

The cash collateral use will expire six months from the date of Egalet’s bankruptcy filing.

Wayne, Pa.-based Egalet is a specialty pharmaceutical company focused on developing pain treatments. The company filed bankruptcy on Oct. 30 under Chapter 11 case number 18-12439.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.